title: [Chronic hepatitis caused by hepatitis E virus and treated with ribavirin].
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, España. Electronic address: ana.mora.soler@gmail.com.
authors.forename: Ana María
authors.initials: AM
authors.lastname: Mora Soler
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, España.
authors.forename: Antonio
authors.initials: A
authors.lastname: Velasco-Guardado
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, España.
authors.forename: María Isabel
authors.initials: MI
authors.lastname: Martín Arribas
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, España.
authors.forename: Rosa
authors.initials: R
authors.lastname: Acosta Materan
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, España.
authors.forename: Cristina
authors.initials: C
authors.lastname: Revilla Morato
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, España.
authors.forename: Daniel
authors.initials: D
authors.lastname: Pérez Corte
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Salamanca, España.
authors.forename: Antonio
authors.initials: A
authors.lastname: Rodríguez Pérez
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001201:Ascites / Q000209:etiology; D004756:Enterobacteriaceae Infections / Q000150:complications / Q000382:microbiology; D005260:Female; D020611:Hafnia alvei / Q000302:isolation & purification; D018380:Hematopoietic Stem Cell Transplantation; D016751:Hepatitis E / Q000188:drug therapy* / Q000209:etiology; D016752:Hepatitis E virus / Q000302:isolation & purification*; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use*; D000069283:Rituximab / Q000627:therapeutic use; D014182:Transplantation, Autologous
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D012254:Ribavirin; D000069283:Rituximab